RAMONA WHITTINGTON: Open Payments
NPI 1609191113 · WESTLAKE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 49 payments from 16 companies in 2025. Trend: 2023 $904 · 2024 $1,435 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $158 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Corium, LLC | 5 | $87 |
| Exact Sciences Corporation | 4 | $69 |
| Abbott Laboratories | 3 | $61 |
| Sumitomo Pharma America, Inc. | 2 | $56 |
| Novo Nordisk Inc | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $36 |
Products named: FARXIGA, Azstarys, VRAYLAR, FREESTYLE LIBRE 3, GEMTESA, The Cologuard Plus Collection Kit, Auvelity, QULIPTA.
Industry payments across LA — which companies pay providers there.
